Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes

PloS One
Baoping LiuYongfeng Jin

Abstract

Induction of mucosal tolerance by oral administration of protein antigens is a potential therapeutic strategy for preventing and treating type 1 diabetes (T1D); however, the requirement for a large dosage of protein limits clinical applications because of the low efficacy. In this study, we generated a fusion protein CTB-Ins-GAD composed of CTB (cholera toxin B subunit), insulin, and three copies of GAD65 peptide 531-545, which were efficiently produced in silkworm pupae, to evaluate its protective effect against T1D. We demonstrate that oral administration of CTB-Ins-GAD suppressed T1D by up to 78%, which is much more effective than GAD65 single-antigen treatment. Strikingly, CTB-Ins-GAD enhance insulin- and GAD65-specific Th2-like immune responses, which repairs the Th1/Th2 imbalance and increases the number of CD4(+)CD25(+)Foxp3(+) T cell and suppresses insulin- and GAD65-reactive spleen T lymphocyte proliferation and migration. Our results strongly suggest that the combined dual antigens promote the induction of oral tolerance, thus providing an effective and economic immunotherapy against T1D in combination with a silkworm bioreactor.

References

Jan 1, 1990·Annual Review of Immunology·L Castaño, G S Eisenbarth
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·I BergerotC Thivolet
May 21, 1999·Advances in Experimental Medicine and Biology·S Ma, A M Jevnikar
Dec 14, 2001·Nature·D MathisC Benoist
Dec 25, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Teresa P DiLorenzoStanley G Nathenson
May 20, 2003·Scandinavian Journal of Immunology·S BregenholtJ S Petersen
Jun 11, 2003·The Journal of Experimental Medicine·Elmar JaeckelHarald von Boehmer
Apr 2, 2004·Proceedings of the National Academy of Sciences of the United States of America·Shengwu MaAnthony M Jevnikar
May 15, 2004·Immunity·Diane Mathis, Christophe Benoist
Mar 3, 2006·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jun Zhou, Dingxian Han
Jun 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tomonori NochiHiroshi Kiyono
Feb 19, 2008·Cellular and Molecular Life Sciences : CMLS·J Sánchez, J Holmgren
Jan 6, 2009·Annals of the New York Academy of Sciences·Jay S SkylerUNKNOWN Type 1 Diabetes TrialNet Study Group
Feb 9, 2010·Nature Immunology·Brian D StadinskiKathryn Haskins
Mar 18, 2010·Plant Biotechnology Journal·Edward P Rybicki
Apr 15, 2011·Immunological Reviews·Howard L WeinerHenry Wu
Jul 19, 2011·Clinical & Developmental Immunology·Qiaohong MengYaozhou Zhang
Aug 13, 2011·Science Translational Medicine·Kevan C Herold, Jeffrey A Bluestone
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Nov 6, 2012·Advanced Drug Delivery Reviews·Xiaomei WangRoland W Herzog
Mar 26, 2013·Nature Reviews. Immunology·Kevan C HeroldJeffrey A Bluestone
Apr 16, 2013·BioMed Research International·Yanli WangEnqi Liu
Nov 15, 2013·Science Translational Medicine·Feyza EnginGökhan S Hotamisligil
Jun 26, 2014·International Journal of Cardiology·Lakshmi MundkurVijay V Kakkar

❮ Previous
Next ❯

Citations

Nov 3, 2020·World Journal of Diabetes·Rui-Feng MaoYe-Fu Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
glycosylation
ELISA
dissection
Fluorescence Activated Cell Sorter

Clinical Trials Mentioned

NCT00419562

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.